Zacks Investment Management’s Prelude Therapeutics PRLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-18,457
Closed -$87.5K 702
2024
Q1
$87.5K Buy
+18,457
New +$87.5K ﹤0.01% 622